Radcliffe Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$2.08M Buy
2022
Q4
$1.33M Hold
2022
Q3
$1.3M Buy
2022
Q2
$1.29M Buy
2022
Q1
$1.27M Buy
2021
Q4
$1M Buy